Barriers to US biosimilar market growth: lessons from biosimilar patent litigation

6 August 2021 - High biologic drug prices have placed substantial strain on the US health care system.  ...

Read more →

Competition from biosimilars drives price reductions for biologics in the French single payer health system

6 August 2021 - France has a single payer health insurance system that has the authority to impose pharmaceutical price reductions ...

Read more →

Full FDA approval is needed to overcome vaccine hesitancy

26 July 2021 - As the Delta variant spreads, what is the agency waiting for? ...

Read more →

Biogen sees heavy patient interest in new Alzheimer’s drug

22 July 2021 - Company pushed back against criticism of drug’s effectiveness and approval, saying trial data supported use. ...

Read more →

Biogen Alzheimer's drug slow to take off as U.S. Medicare wrestles with coverage

21 July 2021 - U.S. hospitals that were expected to be early adopters of Biogen’s Alzheimer’s drug have treated only a ...

Read more →

Drug Utilisation Subcommittee outcome statement

21 July 2021 - The outcome statement from the June 2021 Drug Utilisation Subcommittee meeting is now available. ...

Read more →

DUSC utilisation analysis public release documents

13 July 2021 - The utilisation analysis public release documents from the February 2021 DUSC meeting are now available. ...

Read more →

Factors associated with generic drug uptake in the United States, 2012 to 2017

19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...

Read more →

Uptake of medicines for type 2 diabetes mellitus

15 June 2021 - Empagliflozin (with and without metformin hydrochloride) has been funded since 1 February 2021. It is funded for ...

Read more →

EU regulators develop recommendations to forecast demand of medicines

3 June 2021 - The EU Executive Steering Group on Shortages of Medicines Caused by Major Events has adopted a ...

Read more →

Sandoz Canada congratulates the Quebec government on implementing a shift towards biosimilars

18 May 2021 - The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta ...

Read more →

Almost one-third of adult Australians say they’re unlikely to get COVID vaccination: survey

19 May 2021 - Almost one-third of adult Australians say they are unlikely to be vaccinated against COVID-19 in a ...

Read more →

One in four COVID vaccine doses distributed in Australia not yet administered, figures show

17 May 2021 - New figures show one in four COVID-19 vaccines available in Australia have not been administered, with GP ...

Read more →

CMS expanding efforts to grow COVID-19 vaccine confidence and uptake amongst nation’s most vulnerable

11 May 2021 - CMS builds on whole of Government COVID-19 response with vaccination education, offering and reporting. ...

Read more →

Alberta, Canada, begins mandating switches from originator to biosimilar Humira

6 May 2021 - Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar ...

Read more →